Bio-Reference Laboratories, Inc. - BRLI- Profile

Home » Directory » Health Care » Facilities & Health Systems » Ambulatory Care Centers » Bio-Reference Laboratories, Inc. » Profile

Website: http://www.bioreference.com

Phone: +1 201 791-2600
Address:
481 Edward H Ross Drive
Elmwood Park, NEW JERSEY 07407

Company Description
Bio-Reference Laboratories, Inc.. The Group's principal activity is to provide clinical laboratory testing services to a range of healthcare providers. It offers a range of laboratory testing services including blood and urine analysis, blood chemistry, hematology services, serology, toxicology, tissue pathology and other tissue analysis. Healthcare providers utilize these tests in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The clinical laboratory testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters such as the functions of the heart, kidney, thyroid and other organs. Esoteric tests require sophisticated equipment, materials, highly skilled personnel and professional attention are ordered less frequently than routine tests. Its major customers are doctors, employers, clinics and governmental units. In October 2006, it acquired certain assets of GeneDx Inc. and Diagnosostic Pathology Services Inc. Provides clinical laboratory testing services to a range of healthcare providers
Key People
Chairman, President & Chief Executive Dr. Marc D. Grodman
Executive Vice President & Chief Operating Officer Howard Dubinett
Vice President & Chief Financial Officer Sam Singer

Related Business Topics
Breaking News
Reuters - November 05, 2009 6:21 AM
Continuation of contract that was first initiated in 1998 remains with BioReference ELMWOOD PARK, N.J.--(Business Wire)-- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that the State of New York Department of Correctional Services has ...
CNBC - September 02, 2009 9:13 AM
ELMWOOD PARK, N.J. - Bio-Reference Laboratories Inc. said Wednesday its profit jumped 36 percent in the fiscal third quarter as the effects of the global economic crisis faded. The news sent clinical laboratory operator's shares to all-time highs. In ...
Reuters - September 02, 2009 7:56 AM
* Q3 EPS $0.46 vs est. EPS $0.38 * Q3 rev $97.4 mln vs est. $91.3 mln * Number of patients served up 20 pct in Q3 * Shares hit lifetime high Sept 2 (Reuters) - Bio-Reference Laboratories Inc (BRLI.O) reported a better-than-expected quarterly profit, ...

More Bio-Reference Laboratories News

Overview  |  Profile  |  News  |  Quote & Financials